Tuesday 20 September 2022

FDA approves Aponvie against Postoperative Nausea and Vomiting

FDA approves Aponvie against Postoperative Nausea and Vomiting
FDA approves Aponvie against Postoperative Nausea and Vomiting

Heron Therapeutics, Inc  a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs,  announced that the U.S. Food and Drug Administration (FDA) has approved APONVIE (aprepitant) injectable emulsion, for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults.

Pradip Mahajan Tue, 09/20/2022 - 15:08

source https://www.pharmatutor.org/pharma-news/2022/fda-approves-aponvie-against-postoperative-nausea-and-vomiting

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...